MOFEZOLAC
UNII RVJ0BV3H3Y

Substance Identification & Data

This profile provides standardized clinical and technical data for Mofezolac, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RVJ0BV3H3Y.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 78967-07-4 and the RxNorm Concept ID (RxCUI) 11469. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RVJ0BV3H3Y

CAS Registry Number

78967-07-4

RxNorm Concept ID

11469

Detailed Substance Profile

Preferred Name

MOFEZOLAC

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H17NO5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

DJEIHHYCDCTAAH-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C66176

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

4237

Unique identification number in the NCBI database of chemical substances.

INN ID

6701

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

o1c(CC(O)=O)c(-c2ccc(cc2)OC)c(-c3ccc(OC)cc3)n1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mofezolac. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.